Oral controlled release formulations of an interleukin-1 beta converting enzyme inihibitor

Details for Australian Patent Application No. 2007254990 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Kadiyala, Irina Nikolaevna; Lin, Wu; Hurter, Patricia

Agent Spruson & Ferguson

Pub. Number AU-A-2007254990

PCT Pub. Number WO2007/142951

Priority 60/809,779 31.05.06 US

Filing date 30 May 2007

Wipo publication date 13 December 2007

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/401 (2006.01) - Proline

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/142951 Priority application(s): WO2007/142951

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007254992-Improved shutter slat end retention system

2007254983-Gene methylation in cancer diagnosis